BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 14764527)

  • 21. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.
    Quinn CT; Shull EP; Ahmad N; Lee NJ; Rogers ZR; Buchanan GR
    Blood; 2007 Jan; 109(1):40-5. PubMed ID: 16940426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality in sickle cell disease: A population-based study in an aboriginal community in the Gudalur Valley, Nilgiris, Tamil Nadu, India.
    Sheshadri V; Shabeer P; Santhirapala V; Jayaram A; Krishnamurti L; Menon N
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28875. PubMed ID: 33381914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.
    Hankins JS; Estepp JH; Hodges JR; Villavicencio MA; Robison LL; Weiss MJ; Kang G; Schreiber JE; Porter JS; Kaste SC; Saving KL; Bryant PC; Deyo JE; Nottage KA; King AA; Brandow AM; Lebensburger JD; Adesina O; Chou ST; Zemel BS; Smeltzer MP; Wang WC; Gurney JG
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27228. PubMed ID: 29797644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
    Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
    Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with survival in a contemporary adult sickle cell disease cohort.
    Elmariah H; Garrett ME; De Castro LM; Jonassaint JC; Ataga KI; Eckman JR; Ashley-Koch AE; Telen MJ
    Am J Hematol; 2014 May; 89(5):530-5. PubMed ID: 24478166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.
    Colombatti R; Palazzi G; Masera N; Notarangelo LD; Bonetti E; Samperi P; Barone A; Perrotta S; Facchini E; Miano M; Del Vecchio GC; Guerzoni ME; Corti P; Menzato F; Cesaro S; Casale M; Rigano P; Forni GL; Russo G; Sainati L;
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28868627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Chaturvedi S; DeBaun MR
    Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound.
    Bernaudin F; Arnaud C; Kamdem A; Hau I; Madhi F; Jung C; Epaud R; Verlhac S
    Front Neurol; 2022; 13():846596. PubMed ID: 36188389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.
    Quinn CT; Lee NJ; Shull EP; Ahmad N; Rogers ZR; Buchanan GR
    Blood; 2008 Jan; 111(2):544-8. PubMed ID: 17909076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.
    Worrall D; Smith-Whitley K; Wells L
    J Pediatr Orthop; 2016 Mar; 36(2):139-44. PubMed ID: 25705804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multisystem damage associated with tricorporal priapism in sickle cell disease.
    Sharpsteen JR; Powars D; Johnson C; Rogers ZR; Williams WD; Posch RJ
    Am J Med; 1993 Mar; 94(3):289-95. PubMed ID: 8452153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to reach rapid diagnosis in sickle cell disease?
    Valavi E; Ansari MJ; Zandian K
    Iran J Pediatr; 2010 Mar; 20(1):69-74. PubMed ID: 23056685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dengue in hospitalized children with sickle cell disease: A retrospective cohort study in the French departments of America.
    Elenga N; Celicourt D; Muanza B; Elana G; Hocquelet S; Tarer V; Maillard F; Sibille G; Divialle Doumdo L; Petras M; Tressières B; Etienne-Julan M
    J Infect Public Health; 2020 Feb; 13(2):186-192. PubMed ID: 31548164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pain in sickle cell disease. Rates and risk factors.
    Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
    N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequencies and phenotypic consequences of association of α- and β-thalassemia alleles with sickle-cell disease in Bahrain.
    Abuamer S; Shome DK; Jaradat A; Radhi A; Bapat JP; Sharif KA; Al-Touq J; Al-Asheeri A; Al-Ajami A
    Int J Lab Hematol; 2017 Feb; 39(1):76-83. PubMed ID: 27981798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Children with HbSβ
    Day ME; Rodeghier M; DeBaun MR
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.